Cite
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group
MLA
Jacquelyn N. Crane, et al. “Clinical Group and Modified TNM Stage for Rhabdomyosarcoma: A Review from the Children’s Oncology Group.” Pediatric Blood & Cancer, vol. 69, Mar. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....97902c10ee022ce946e8f7ce24c1bc52&authtype=sso&custid=ns315887.
APA
Jacquelyn N. Crane, Wei Xue, Amira Qumseya, Zhengya Gao, Carola A. S. Arndt, Sarah S. Donaldson, Douglas J. Harrison, Douglas S. Hawkins, Corinne M. Linardic, Leo Mascarenhas, William H. Meyer, David A. Rodeberg, Erin R. Rudzinski, Barry L. Shulkin, David O. Walterhouse, Rajkumar Venkatramani, & Aaron R. Weiss. (2022). Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children’s Oncology Group. Pediatric Blood & Cancer, 69.
Chicago
Jacquelyn N. Crane, Wei Xue, Amira Qumseya, Zhengya Gao, Carola A. S. Arndt, Sarah S. Donaldson, Douglas J. Harrison, et al. 2022. “Clinical Group and Modified TNM Stage for Rhabdomyosarcoma: A Review from the Children’s Oncology Group.” Pediatric Blood & Cancer 69 (March). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....97902c10ee022ce946e8f7ce24c1bc52&authtype=sso&custid=ns315887.